Characterization of a monoclonal antibody inhibiting the biological activity of human chorionic gonadotrophin.
A mouse monoclonal antibody (MCA), raised against human chorionic gonadotrophin (HCG) and coded 130A, was characterized with several types of immunoassay and with in-vitro and in-vivo bioassays. MCA 130A binds strongly to the intact HCG molecule but less so to either alpha- or beta-subunit; The dissociation constant of the MCA-HCG complex was found to be in the order of 70 pmol/l. MCA 130A inhibits the biological activity of HCG very effectively, both in vitro and in vivo. In a competitive immunoassay MCA 130A binds 30 x better to HCG than to human luteinizing hormone (HLH). The selectivity in the bioassays was much higher, e.g. in vitro, 50% inhibition of HLH-stimulated testosterone production requires 2600 x as much MCA as is needed for inhibiting HCG-stimulated production. Possible reasons for this difference in selectivity are discussed.